Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (9) , 857-860
- https://doi.org/10.1111/j.1198-743x.2004.00946.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitorInternational Journal of Antimicrobial Agents, 2003
- Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor.Journal of Antimicrobial Chemotherapy, 2002
- In Vitro Activities of Peptide Deformylase Inhibitors against Gram-Positive PathogensAntimicrobial Agents and Chemotherapy, 2002
- Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance DevelopmentAntimicrobial Agents and Chemotherapy, 2001
- Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase InhibitorAntimicrobial Agents and Chemotherapy, 2001
- Peptide deformylase as a target for new generation, broad spectrum antimicrobial agentsMolecular Microbiology, 2000